DOGE slashes research funds to private medical sector, scientists warn China could snatch America’s brightest minds

The Department of Government Efficiency (DOGE), an unofficial cost-cutting group led by Elon Musk, has implemented significant reductions in research funding for the private medical sector. Specifically, the National Institutes of Health (NIH) has capped indirect cost rates at 15%, down from an average of 30%. Indirect costs, which include utilities, administrative salaries, and maintenance, are essential for research institutions to operate. This cut means private research institutions, universities, and hospitals must now cover more of these costs themselves, potentially leading to budget deficits and reduced research capabilities.

Why scientists are worried about China

Scientists are concerned that these funding cuts could trigger a brain drain, with America's brightest minds moving to China. China has been heavily investing in science and technology, offering competitive salaries, advanced facilities, and a supportive environment for researchers. For example, Tianjin University in northern China has hired an American professor to lead its pharmaceutical science program, recruiting students globally with classes taught in English. This shows China's efforts to attract international talent, especially as US funding tightens.

A surprising shift: China's growing appeal

It's surprising that despite the US's historical leadership in medical research, China's aggressive funding and recruitment strategies are now pulling US scientists. Richard B. Silverman, a chemistry professor at Northwestern University, noted on X that "the Chinese government is really pushing to become a leader in science and technology, and they see that as a way to become a superpower," with some of his former students already moving there for better opportunities.

Background on DOGE and the funding cuts

DOGE, as mentioned in a BBC article, is an initiative led by Elon Musk, aimed at reducing government expenditure. One of its recent actions has been to influence the NIH to cut funding for indirect costs, which are essential for the operation of research institutions. The NIH, the largest funder of biomedical research in the world, announced on February 7, 2025, that it would cap the rates grants pay for indirect research costs at 15%, half of the current average rate of 30%, as reported by TIME. This decision, estimated to save $4 billion, was justified by the NIH as a way to ensure more funds go towards direct scientific research costs rather than administrative overhead, according to the Washington Post.

Impact on the private medical sector

The reduction in indirect cost coverage is causing severe financial strain for the private medical sector, which includes research institutions, universities, and hospitals. The New York Times highlighted that these changes could reduce research grants by billions, potentially discouraging future research and leading to layoffs and funding freezes. Missouri Independent reported that Missouri universities and research organizations could lose about $100 million from NIH-funded research, affecting vital work that saves lives and creates jobs. Researchers like Dr. Richard Huganir from Johns Hopkins University, quoted in NBC News, expressed disbelief at the cut, worrying it could stall decades of work, calling it the "apocalypse of American science."